Holen Sie sich die Stockscreener-App
10.35
7.17%
-0.80
Handel nachbörslich:
10.46
0.11
+1.06%
Schlusskurs vom Vortag:
$11.15
Offen:
$11.78
24-Stunden-Volumen:
113.20K
Relative Volume:
0.71
Marktkapitalisierung:
$333.25M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-61.19%
1M Leistung:
+90.61%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$10.12
$11.90
1-Wochen-Bereich:
$9.00
$33.66
52-Wochen-Spanne:
$4.40
$33.66
Liminatus Pharma Inc Stock (LIMN) Company Profile
Firmenname
Liminatus Pharma Inc
Sektor
Branche
Telefon
213-273-5453
Adresse
6 CENTERPOINTE DR., LA PALMA
Vergleichen Sie LIMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LIMN
Liminatus Pharma Inc
|
10.35 | 333.25M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.16 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
534.91 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.06 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
542.47 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
245.16 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Liminatus Pharma Inc Aktie (LIMN) Neueste Nachrichten
Why Is Liminatus Pharma Inc (LIMN) Up 83%? Unpacking the Surge - Wealth Daily
KH Group's investment in US biotech Liminatus Pharma halves in one day - Chosun Biz
Liminatus Pharma Stock Surges to Record High After Regaining Nasdaq Compliance - MSN
Liminatus Pharma stock gains on regaining compliance with Nasdaq - MSN
Greif Posts Upbeat Earnings, Joins Planet Labs PBC, IperionX, Owens & Minor And Other Big Stocks Moving Higher On Thursday - Benzinga
Crude Oil Moves Higher; Ciena Posts Downbeat Earnings - Benzinga
Dow Dips Over 100 Points; US Jobless Claims Increase - Benzinga
Liminatus Pharma shares soar on Nasdaq compliance news By Investing.com - Investing.com Canada
Liminatus Pharma shares soar on Nasdaq compliance news - Investing.com Australia
Pre-market Movers: LIMN, KRON, HSDT, CBUS... - RTTNews
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Liminatus Pharma Gains Compliance With Nasdaq Filing Requirements; Shares up Pre-Bell - marketscreener.com
Liminatus Pharma regains Nasdaq listing compliance - TipRanks
Liminatus Pharma Regains Nasdaq Compliance After Filing Delay - TipRanks
Liminatus Pharma, Inc.Class A Common Stock (Nasdaq:LIMN) Stock Quote - FinancialContent
Liminatus Pharma Delays Quarterly Report Filing - TipRanks
Liminatus Pharma’s Merger with Iris Acquisition Corp. - Global Legal Chronicle
Iris Acquisition, Liminatus Pharma Sign SPAC Merger Deal - marketscreener.com
LIMN Stock Price and Chart — NASDAQ:LIMN - TradingView
Iris Acquisition Corp confirms delisting and shareholder vote outcomes - Investing.com
Iris Acquisition Corp announces preliminary proxy statement - Investing.com
Iris Acquisition Corp announces business combination - Investing.com
Iris Acquisition Corp announces business combination with Liminatus Pharma - Investing.com
New company Liminatus Pharma Inc to develop three cancer treatments - Labiotech.eu
A fledgling biotech goes SPAC route to bankroll cancer vaccine, CAR-T and CD47 - Endpoints News
Liminatus Pharma and Iris Acquisition to Combine in $334M Deal - The SPAC Conference
Liminatus Pharma and Iris Acquisition Corp to Combine - citybiz
Holland & Knight Partner Seth Belzley Ranked Among Denver’s Outstanding "40 Under 40" Business Professionals - Holland & Knight
Finanzdaten der Liminatus Pharma Inc-Aktie (LIMN)
Es liegen keine Finanzdaten für Liminatus Pharma Inc (LIMN) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.39%
0.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):